Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Drug Policy (Second Edition) - Ghana (GNDP; 2004; 37 pages)
View the documentPREFACE
View the documentACKNOWLEDGEMENT
View the documentLIST OF ACRONYMS
View the documentINTRODUCTION
View the documentGOAL
View the documentOBJECTIVES
View the documentSITUATIONAL ANALYSIS
Open this folder and view contents1.0 DRUG SELECTION
Open this folder and view contents2.0 DRUG PROCUREMENT, STORAGE AND DISTRIBUTION
Open this folder and view contents3.0 DRUG FINANCING
close this folder4.0 QUALITY ASSURANCE
View the document4.1 Preamble
View the document4.2 Objective
close this folder4.3 Policy statement
View the document4.3.1 Quality of Drugs.
View the document4.3.2 Drug Registration
View the document4.3.3 Quality of service
View the document4.3.4 Drug Advertisement and Promotion
Open this folder and view contents5.0 LOCAL MANUFACTURE OF PHARMACEUTICAL AND TRADITIONAL MEDICINAL PRODUCTS
Open this folder and view contents6.0 RATIONAL DRUG USE
Open this folder and view contents7.0 GLOBAL TRADE AND PHARMACEUTICALS
Open this folder and view contents8.0 EMERGING DISEASES AND PHARMACEUTICALS
Open this folder and view contents9.0 HUMAN RESOURCE DEVELOPMENT FOR DRUG MANAGEMENT
Open this folder and view contents10.0 TRADITIONAL MEDICINAL PRODUCTS
Open this folder and view contents11.0 RESEARCH AND DEVELOPMENT
Open this folder and view contents12.0 NATIONAL DRUG POLICY IMPLEMENTATION
View the documentANNEX A: DEFINITIONS
View the documentANNEX B: RELEVANT REGULATIONS ON PHARMACEUTICALS
 

4.3.4 Drug Advertisement and Promotion

4.3.4.1 All advertisements and promotion of drugs shall be of high ethical standards.

4.3.4.2 All drugs to be advertised or promoted shall be registered with the Food and Drugs Board (FDB).

4.3.4.2 The FDB shall be responsible for monitoring and ensuring ethical standards for drug advertisement and promotion in accordance with the Food and Drugs Law 1992 (PNDCL 305B) and shall collaborate with other agencies to achieve this objective.

4.3.4.3 Public advertising materials on drugs, whether in the print or electronic media shall be vetted by the FDB and the approval of the Board shall be obtained before the material is used.

4.3.4.4 Drug promotional activities shall be in line with the National Drugs Policy objectives. In this respect, whenever the brand name of a drug is used in any form of promotional or educational material, the generic name of the drug shall be given due prominence. In the case of printed materials, such as advertisements on billboards, posters and publications, the generic name shall be prominent and positioned underneath the brand name.

4.3.4.5 Promotion and advertisements of Prescription-only Medicines (POM) and Pharmacist recommended medicine (P) shall be restricted to health professional publications only.

4.3.4.6 Promotion and advertising of drugs shall not be permitted at public places including lorry parks and markets and in all modes of transportation except approved by regulations under the Food and Drugs Law 1992 (PNDCL 305B).

4.3.4.7 No advertisement shall be permitted for drugs and herbal medicines for disease conditions specified in schedule 2 of the Food and Drugs Law 1992 (PNDCL 305B).

to previous sectionto next section
Please provide your feedback English  |  French